Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.